Naloxone Hydrochloride
Product Images NDC 67296-2050

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 67296-2050). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

This text provides information on the different doses and routes of administration for naloxone, a medication used to reverse opioid overdose. The text includes details on the plasma concentration of naloxone in ng/mL, dosages in milligrams, and instructions for administration through nasal spray and intramuscular injection at various time points post dose.*

FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

This text appears to describe different dosages of naloxone administration, including the amount in milligrams and milliliters to be sprayed in each nostril or injected intramuscularly. It also includes a reference to naloxone plasma concentration in ng/mL and a time frame "Hours Postdose". This information can be used to understand the recommended dosages and timing for naloxone administration in cases of opioid overdose.*

FDA Label Image

Step 3 (2y2 Step 3)

FDA Label Image

Step 4 (2y2 Step 4)

FDA Label Image

Step 5 (2y2 Step 5)

FDA Label Image

Step 7 (2y2 Step 7)

This text provides instructions on how to position the hand to support the head and knee effectively to stop the body from rolling onto the stomach. It emphasizes the importance of proper support to maintain a comfortable and stable position.*

FDA Label Image

Label (Quick Start Image)

This is a description of a nasal spray containing Naloxone HCI, used only in the nose as prescription medication. Each dose provides 4 mg of naloxone HCI equivalent to 36 mg in 0.1 mL spray. It should be stored below 77°F and protected from excessive heat and light. The nasal spray is intended for use in cases of known or suspected overdoses in adults.*

FDA Label Image

Carton Principle Display Panel (Carton Image 1)

This text is a description of a Naloxone HCl Nasal Spray used for known or suspected opioid overdose in adults and children. The product comes with two 4-mg doses and has instructions on how to administer the spray in case of an opioid overdose. The text highlights the importance of using the spray for nasal use only and emphasizes checking the product expiration date before use. The detailed instructions provided include identifying signs of opioid overdose and administering the nasal spray to the person in need. This product is intended for use in emergency situations only.*

FDA Label Image

Carton Principle Display Panel Body (Carton Image 2)

The text contains instructions for administering Naloxone HCl Nasal Spray, an opioid antagonist used in cases of opioid overdose. It provides step-by-step guidance on how to give the spray through the nostrils, monitor the person closely, and when to seek emergency medical help. It includes dosage information, storage instructions, and details about the product contents. The text also mentions the manufacturer information and contact details for more information.*

FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Step 2 (Image 01)

FDA Label Image

Serialization (Image 06)

This is a template for recording product information including the serial number, lot number, and expiration date. The user would need to insert the specific details for each product being evaluated.*

FDA Label Image

Step 1 (Quick Start Guide Step 1)

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

This text provides a list of items related to a mechanical system. The first item is "Nozzle" and the second item is "Plunger". These items are commonly found in machines or devices that require fluid or liquid handling.*

FDA Label Image

Step 3 (Quick Start Guide Step 3)

This text appears to provide instructions related to the proper positioning and support for a baby. It mentions the importance of supporting the head and preventing the body from rolling onto the stomach by using the hand and knee for stability. These guidelines can be crucial for ensuring the safety and comfort of infants during handling and care.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.